Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Original Drug Port Life Science Group is a specialized healthcare company based in the Hainan Free Trade Port, China, focusing on the acceleration of innovative drug entry into the Chinese market. The company operates as an integrated platform that provides regulatory consulting, clinical trial management, and commercialization services for global pharmaceutical and biotech firms. By leveraging the unique 'Lecheng Pilot Zone' policies, they facilitate the early clinical use of advanced foreign drugs and medical devices before full NMPA approval. Their business model bridges the gap between international drug developers and the Chinese healthcare ecosystem through strategic partnerships and specialized supply chain solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Original Drug Port Life Science Group.